When Recursion launched in 2013, the fledgling biotech’s goal was to turn machine vision loose on images of cells, at scale, to better understand the biology of disease. Exscientia, founded the year ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback